Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisinopril and verapamil effects on kidney injury biomarkers in hypertensive patients with type 2 diabetes mellitus and nephropathy
PACTR201907856711564Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of lisinopril and verapamil in diabetic glomerulosclerosis, hypertension (HTN) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Ain Shams University. Primary endpoints: Urinary albumin creatinine ratio, Endostatin and 1 more. Status: unknown.
02
Drugs
lisinoprilverapamil
03
Conditions
diabetic glomerulosclerosishypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on PACTR201907856711564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201907856711564.